A Phase 2, Open Label Study of PEmigatinib and REtifanlimab in Advanced Dedifferentiated LIposarcoma (PERELI)

Name: A Phase 2, Open Label Study of PEmigatinib and REtifanlimab in Advanced Dedifferentiated LIposarcoma (PERELI)
License: Public Domain

Lund University Hospital

ClinicalTrials.gov · Datasets · License: Public Domain

dedifferentiated liposarcoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 181775
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.